The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

AAPS 2025 PharmSci 360

Advancing excellence in OSD and small molecule development

Connecting sponsors with a global network of expertise and CDMO capabilities.

Booth #2925 | November 9–12, 2025 | San Antonio, Texas

About AAPS 2025 PharmSci 360

AAPS  PharmSci 360 is an annual event organized by the American Association of Pharmaceutical Scientists (AAPS). The event convenes thousands of pharmaceutical science professionals from around the world and across the drug development process to discuss the latest advancements in pharmaceutical science and technology.

 

Add these sessions to your agenda


Unlocking the Limit of Congruency: Copovidone ASD Innovation from Lab to Commercial Scale

Date: Monday, November 10, 2025
Time: 12:30 PM - 1:30 PM CT
Location: 360 Stage 4, Exhibit Hall

Presenters:
Nitin Kumar K. Swarnakar, Ph.D., NA Applications Lab Manager, BASF Corporation
Ramesh Muttavarapu, MS, Global SME for Solid Orals, Thermo Fisher Scientific 

Unlock the next phase of innovation in pharmaceutical formulation. The co-presenters will highlight the science and practical considerations behind maximizing drug loading while ensuring consistent dissolution performance and manufacturing robustness. Case studies and process optimization examples will demonstrate how to anticipate challenges, avoid development pitfalls, and accelerate your path to successful ASD commercialization.

Read the full session description here

Event details 

Date: November 9-12, 2025

Formant: In-person

Location: Henry B. Gonzalez Convention Center, San Antonio, Texas

Booth number: #2925

Event website: https://www.aaps.org/pharmsci/annual-meeting

Rewriting the Rules: How Digital Tools Are Disrupting Drug Development

Date: Monday, November 10, 2025
Time: 3:30 PM - 4:30 PM CT
Location: 360 Stage 4, Exhibit Hall

Presenters:
Anil Kane, PhD, Sr. Director, Global Technical Scientific Affairs, Thermo Fisher Scientific
Sanjay Konagurthu, PhD, Sr. Director, Science and Innovation, Thermo Fisher Scientific

The future of drug development is here. See how Thermo Fisher is transforming pharma with predictive modeling, AI-powered manufacturing, and real-time adaptive control. From cutting API waste to boosting efficiency and quality, this session reveals how digital tools are reshaping development timelines and unlocking breakthroughs.

Presented by our in-house experts, Anil Kane, PhD, sr. director, global technical scientific affairs; and Sanjay Konagurthu, PhD, sr. director, science and innovation.

Read the full session description here

Expand your knowledge base


Poster presentations

Experience Thermo Fisher Scientific’s expertise through a collection of posters that highlight the digital models at the forefront of drug development, including our own OSDPredict.

Each poster distills the rigorous work of our scientists and demonstrates how our “science first” approach lays the foundation for digital innovation.

  • AI/ML Model Informed Early-Stage Drug Development
  • Evaluation of Spray Dried and Nanomilled Formulations on Pharmacokinetics Using Predictive Modeling
  • Predictive Stability Modeling of Softgels
  • De-Risking Tablet Formulation Development Using Compaction Simulation
  • Evaluation of Tableting Characteristics of Copovidone-Based ASDs Using CTC and Heckel Analysis
  • Impact of Dosage Form on Drug Release from Danazol-ASD at LoC: A Comparative Study
  • Efficient Manufacturing of Omeprazole Modified-Release pellets using Talc-Free Aqueous Coating System
  • Compression Process Optimization Using a 2^3 Full Factorial Design of Experiments
  • Optimization of Roller Compaction Process Parameters and Roller Design of Poorly Flowing Powder Blend

Let’s connect at AAPS 2025 PharmSci 360, November 9-12

Developing oral solid dose and small molecule products involve countless critical decisions at every stage and “business as usual” is not a successful strategy. Where speed and efficiency are paramount, AI-driven tools and digital innovations embedded in the right place can help developers realize these objectives.

Visit us at Booth #2925 to explore our comprehensive CDMO capabilities specific to small molecule and OSD development and  the modern technologies we utilize to enhance the efficiency, accuracy, and speed of the drug development processes.

Got questions? Want to discuss your project? Talk with one or our experts at Booth #2925

We look forward to meeting you in Texas.

 

Continuing education for the pharma industry 

 

Follow us on social for event updates

We look forward to seeing you soon